Advertisement
Retraction|Articles in Press

WITHDRAWN: Germline testing of patients with non-small cell lung cancers demonstrating incidentally uncovered BRCA2 apparent pathogenic germline variants

Published:December 24, 2021DOI:https://doi.org/10.1016/j.cllc.2021.12.007
WITHDRAWN: Germline testing of patients with non-small cell lung cancers demonstrating incidentally uncovered BRCA2 apparent pathogenic germline variants
Previous ArticleDUPLICATE: Cancers of the Pancreas Update 2023
Next ArticleWITHDRAWN: Progression patterns of metastatic lung adenocarcinoma patients with EGFR mutation
      This paper is only available as a PDF. To read, Please Download here.
      The Publisher regrets that this article is an accidental duplication of an article that has already been published, https://doi.org/10.1016/j.cllc.2022.07.011. The duplicate article has therefore been withdrawn.
      The full Elsevier Policy on Article Withdrawal can be found at https://www.elsevier.com/about/our-business/policies/article-withdrawal.

      Article info

      Publication history

      Publication stage

      In Press Journal Pre-Proof

      Identification

      DOI: https://doi.org/10.1016/j.cllc.2021.12.007

      Copyright

      © 2021 Elsevier Inc. All rights reserved.

      ScienceDirect

      Access this article on ScienceDirect

      The content on this site is intended for healthcare professionals.


      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the Cookie Preference Center for this site.
      Copyright © 2023 Elsevier Inc. except certain content provided by third parties.


      RELX